The cosmetics use of phosphatidylcholine in the treatment of localized fat deposits

Cosmetic Dermatology

Volumn 19, Issue 6, 2006, Pages 416-420

  Myers, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALOE VERA EXTRACT; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; COSMETIC; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHOSPHATIDYLCHOLINE;

ADULT; ALLERGIC REACTION; ARTICLE; CLINICAL EFFECTIVENESS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFECTION; INJECTION SITE BURNING; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; LIPIDOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN GLOBAL IMPROVEMENT; RATING SCALE; REGRESSION ANALYSIS; SKIN DEFECT; SKIN DISCOMFORT; SKIN INFLAMMATION; SKIN NODULE; SKIN PIGMENTATION; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; TISSUE NECROSIS; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 33745380716     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Galeone FS, Salvadorini F, Pagliai E, et al. Effects of soybean polyunsaturated phosphatidylcholine (Lipostabil) on hyperlipoproteinemia. Curr Ther Res. 1978;24:299-305.
2. Rotunda AM, Suzuki H, Moy RL, et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg. 2004;30:1001-1008.
3. Almazov VA, Freidlin IS, Krasil'nikova EI. Use of Lipostabil to correct lipid metabolism disorders in patients with ischemic heart disease [in Russian]. Kardiologiia. 1986;26:39-42.
4. Maggiori S. Traitement mesoterapique des xanthelasmas a la phosphatidilcoline poluinsaturee (EPL). V Congres Internacional de Mesotherapie, Paris: Dermatologie; 1988;364-366.
5. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg. 2003;27:315-318.
6. Hexsel D, Serra M, Mazzuco R, et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol. 2003;2:511-518.
7. Kardorff B, Gansel RW, Tast R, et al. 2004 Lipodissolve clinical report. Available at: http://www.asal-meso.com/html/news/june_ 1B_2005_news.htm. Accessed May 9, 2006.
8. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg. 2001;27:391-392.
9. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg. 2004;30:422-427.